Skip to content
Open access

Interaction of Candida spp. fungi with immune effectors

Oct 2026 · Russian Journal of Immunology · 0 citations · 9 references

Abstract

Candida spp. are surviving in human biotopes under constant exposure to innate and adaptive immune factors, using the mechanisms which suppress/neutralize the host's antimicrobial defenses. Furthermore, the aggressiveness of Candida spp. is mediated by a number of their pathogenicity factors, especially, those providing adhesion to host mucous membranes and medical device surfaces, their ability to form biofilms, and secretion of hydrolytic enzymes (e.g., proteases, phospholipases, and hemolysins). The body's resistance to infections caused by Candida spp. is mediated primarily by polymorphonuclear leukocytes and macrophages. Candida antigens stimulate lymphocyte proliferation and cytokine synthesis, which, in turn, enhance the candidacidal functions of phagocytic cells. Furthermore, Candida spp. has evolved various mechanisms to counteract the host's natural defenses, allowing them to persist intracellularly and even replicate within the phagosomes of neutrophils and macrophages. This property underlies the tendency of candidiasis to become chronic and recurrent. Candida spp. possess a multi-stage strategy for evading the host's immune defenses, enabled by secretion of various proteases by the fungal cells. These proteases are capable of inactivating the effectors of innate immune response (C3b, C4b, C5 components of the complement system, lactoferrin, lysozyme) and adaptive immunity (IgG), as well as elements of cytokine regulation, thus significantly reducing the host's antimicrobial defenses. Of particular note is the recently discovered anticytokine activity in Candida spp., being shown against IL-6, IL-8, IL-10, and TNFα, as well as their ability to produce cytokine-like substances that was described for the first time. Furthermore, the fungi exhibited intrageneric (interspecies) and intraspecific (interstrain) variability in presence, incidence, and severity of these properties. Future studies of interactions between fungi and immune effectors will help to justify new approaches to the treatment and prevention of mycoses, including those caused by Candida spp.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.